Legacy health System
Portland, Oregon, 97210, United States
NCT Number: NCT01174069
Hypothesis: Natural orifice transgastric cholecystectomy with laparoscopic assist will be feasible and have comparable complication rates as standard lap cholecystectomy. Patient benefits will include less pain and scaring.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Portland, Oregon, 97210, United States
In this study, we propose to use a surgical technique that eliminates the need for a 1.5-2.5 cm umbilical incision. A flexible endoscope will be inserted through the mouth and into the stomach. Using commercially available endoscopes, endoscopic instruments and accessories, a small incision will be made in the gastric wall and the endoscope will be advanced into the insufflated peritoneal cavity. Two to three small laparoscopic trocars will be placed for laparoscopic instrument insertion to manipulate, retract and cut tissue. The flexible endoscope will provide visualization of the surgical field and flexible endoscopic instruments may be used to augment surgical manipulation with the laparoscopic instruments. Once dissected free, the gall bladder will be removed through the stomach and out of the mouth. Commercially available endoscopic clips, sutures and/or tissue anchors will be used to close the gastrotomy; additionally, the gastrotomy will be tested for leaks and laparoscopically oversewn with suture as needed.
Patients will be discharged per the standard of practice for a laparoscopic cholecystectomy. During the hospital stay severity of pain and use of pain medications will be recorded. Length of time spent in the recovery room and in the hospital will also be collected. Patients will return and be evaluated by their surgeon two weeks following their procedure. At this visit, any complications will be noted in the patient's medical record. Additionally at this visit and at the preoperative visit, patients will complete a standardized Quality of Life (QOL) assessment (i.e., SF-36) and perceived pain levels and type and frequency of pain medications will be recorded in the patient's medical record.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical removal of the gallbladder using endoscopic instruments.
Other names: NOTES Cholecystectomy
Time frame: 30 days
perceived pain levels and type and frequency of pain medications will be recorded in the patient's medical record.
Time frame: 30 days post operatively
standardized Quality of Life (QOL) assessment (i.e., SF-36) form filled out by the patient.
The Oregon Clinic
Other
Clinical Outcomes Trial of Laparoscopic Assisted Transgastric Endoscopic Cholecystectomy
Acronym: NOTESchole
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06005701
Behavior, Bile Duct Diseases
Buraidah, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT06502028
Biliary Tract Diseases, Cholecystitis
Seoul, South Korea
View Trial DetailsNCT06198335
Biliary Tract Diseases, Cholecystitis
Bursa, Turkey (Türkiye)
View Trial DetailsNCT06981052
Biliary Tract Diseases, Cholecystitis
Worcester, Massachusetts, United States
View Trial Details